These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11685792)

  • 1. Advances in therapy for chronic hepatitis C.
    Fried MW
    Clin Liver Dis; 2001 Nov; 5(4):1009-23. PubMed ID: 11685792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving treatment of chronic hepatitis C: where we stand a decade out.
    Saadeh S; Davis GL
    Cleve Clin J Med; 2004 May; 71 Suppl 3():S3-7. PubMed ID: 15468610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in treatment of chronic hepatitis C: 'pegylated' interferons.
    Sharieff KA; Duncan D; Younossi Z
    Cleve Clin J Med; 2002 Feb; 69(2):155-9. PubMed ID: 11990646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
    Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated IFNs for chronic hepatitis C: an update.
    Grace MJ; Cutler DL; Bordens RW
    Expert Opin Drug Deliv; 2005 Mar; 2(2):219-26. PubMed ID: 16296749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin.
    Fried MW; Hadziyannis SJ
    Semin Liver Dis; 2004; 24 Suppl 2():47-54. PubMed ID: 15346246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis C: initial treatment in patients without previous treatment].
    Diago M
    Gastroenterol Hepatol; 2002 May; 25(5):347-55. PubMed ID: 11985813
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic hepatitis C with pegylated alpha-interferons].
    Niederau C
    Dtsch Med Wochenschr; 2002 Mar; 127(11):563-6. PubMed ID: 11894177
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M; Wedemeyer H; Manns MP
    Curr Gastroenterol Rep; 2002 Feb; 4(1):23-30. PubMed ID: 11825538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of sarcoidosis-associated chronic hepatitis C virus infection: course and treatment].
    Longueira Suárez R; Ammari I; Lamas Ferreiro JL; Sopeña Pérez-Argüelles B; Martínez-Vázquez C
    Rev Clin Esp; 2009; 209(7):358-9. PubMed ID: 19709544
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of chronic Hepatitis C in 2008].
    Niederau C; Kaden T
    MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-responders to previous treatment for hepatitis C.
    Gross JB
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):47-54. PubMed ID: 15756145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus.
    Foster GR
    Expert Opin Pharmacother; 2003 May; 4(5):685-91. PubMed ID: 12739994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoadamantanes for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus therapy to date.
    Foster G; Mathurin P
    Antivir Ther; 2008; 13 Suppl 1():3-8. PubMed ID: 18432157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
    Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C
    J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present treatment expectations and risks of chronic hepatitis C.
    Carreño V
    Clin Microbiol Infect; 2002 Feb; 8(2):74-9. PubMed ID: 11952719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.